SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : NEOTHERAPEUTICS (NEOT) (NEOTW) -- Ignore unavailable to you. Want to Upgrade?


To: xbrent who wrote (331)5/20/1998 8:50:00 PM
From: JEFF CHAPMAN  Respond to of 705
 
Briefing.com on NEOT:

briefing.com



To: xbrent who wrote (331)5/20/1998 9:49:00 PM
From: Dennis Lee (Hijacked)  Read Replies (2) | Respond to of 705
 
NEOT and ENMD NEOT has a float of 3.9 mil vs ENMD's 5.9 mil. NEOT's drug was tested on human. ENMD was on mice. ENMD sold down after the unreal gap open. Less likely for a short squeeze. Given all these, I would say NEOT should trade better than 25.